AMG – 714 is Back!

I thought AMG-714 was dead. In Phase 2 clinical trials, AMG-714 failed to meet its objective. The objective was to minimize or eliminate damage to the small intestine on a gluten containing diet for those with celiac disease. However, in analyzing the data, scientists found that it helped reduce symptoms in those on a gluten free diet. So, they are starting another clinical trial and I've got all the details here!!!